Nafamostat
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0081525-10-2
Chemical Formula
C19-H17-N5-O2
Molecular Weight
347
Therapeutic Category
Protease inhibitor
Chemical Name
Benzoic acid, 4-[(aminoiminomethyl)amino]-, 6-(aminoiminomethyl)-2-naphthalenyl ester
Foreign Names
- Nafamostatum (Latin)
- Nafamostat (German)
- Nafamostat (French)
- Nafamostat (Spanish)
Generic Names
- Nafamostat Mesilate (OS: JAN)
- Nafamostat Mesylate (OS: USAN)
- FUT 175 (IS)
- Nafamostat Mesilate (PH: JP XV)
Brand Names
- Berabu
Tobishi Pharmaceutical, Japan - Buipel
Taiyo Pharmaceutical, Japan - Buseron
Sawai Seiyaku, Japan - Coahibitor
Ajinomoto, Japan - Famoset
Towa Yakuhin, Japan - Futhan
SK Chemical Life Science, South Korea; Torii Yakuhin, Japan - Mofsart
CHO Shinyaku, Japan - Nafamostat
Kobayashi Kako, Japan - Nafaston
Fuji Yakuhin, Japan - Namostatt
Pola Pharma, Japan - Naotamin
Asahi Kasei Pharma, Japan - Opsun
Sanwa Kagaku, Japan - Ronastat
Isei, Japan
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
